These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tuberculosis in patients treated with tumor necrosis factor-alpha antagonists living in an endemic area. Is the risk worthwhile? Rojas-Villarraga A; Agudelo CA; Pineda-Tamayo R; Porras A; Matute G; Anaya JM Biomedica; 2007 Jun; 27(2):159-71. PubMed ID: 17713627 [TBL] [Abstract][Full Text] [Related]
23. Hepatosplenic T-cell lymphomas and therapy with TNF-alpha-blocking biologics: a risk for psoriasis patients? Beyer M; Steinhoff M; Anagnostopoulos I; Assaf C; Sterry W J Dtsch Dermatol Ges; 2009 Mar; 7(3):191-4. PubMed ID: 19192165 [TBL] [Abstract][Full Text] [Related]
24. How to manage infections in the era of biologics? Saraceno R; Chimenti S Dermatol Ther; 2008; 21(3):180-6. PubMed ID: 18564248 [TBL] [Abstract][Full Text] [Related]
25. Adverse effects of biological agents in the treatment of psoriasis. Rongioletti F; Burlando M; Parodi A Am J Clin Dermatol; 2010; 11 Suppl 1():35-7. PubMed ID: 20586505 [TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor inhibitors and infection complications. Crawford M; Curtis JR Curr Rheumatol Rep; 2008 Oct; 10(5):383-9. PubMed ID: 18817643 [TBL] [Abstract][Full Text] [Related]
33. Morphea, an unusual side effect of anti-TNF-alpha treatment. Mattozzi C; Richetta AG; Cantisani C; Giancristoforo S; D'Epiro S; Gonzalez Serva A; Viola F; Cucchiara S; Calvieri S Eur J Dermatol; 2010; 20(3):400-1. PubMed ID: 20299314 [No Abstract] [Full Text] [Related]
34. [Tumor necrosis factor blocking agents: a review. Part II: safety and recommendations]. Rodríguez Moreno C; López Vázquez P; Durán Parrondo C; Tato Herrero F; Lado Lado F; Velasco González M An Med Interna; 2006 Feb; 23(2):86-92. PubMed ID: 16566659 [TBL] [Abstract][Full Text] [Related]
35. Uncovering the risks of immunosuppressive therapy in patients with uveitis. Goldstein DA Arch Ophthalmol; 2009 Jun; 127(6):799-800. PubMed ID: 19506201 [No Abstract] [Full Text] [Related]
36. Anti-TNF-alpha therapy for orofacial granulomatosis: proceed with caution. Gaya DR; Aitken S; Fennell J; Satsangi J; Shand AG Gut; 2006 Oct; 55(10):1524-5. PubMed ID: 16966709 [No Abstract] [Full Text] [Related]